OnQuality Announces FDA Clearance of IND Application for OQL051, for the Prophylaxis of Chemotherapy-Induced Diarrhea
SEATTLE, June 6, 2023 /PRNewswire/ — OnQuality Pharmaceuticals (“OnQuality”), a targeted oncology supportive therapy company developing innovative medications to address unmet needs in oncodermatology and oncogastroenterology (cancer therapy-induced toxicities occurring in the skin and gastrointestinal tract) and to improve the quality of life for patients receiving anticancer medications, announced today the U.S. Food and Drug … Read more